Skip to main content
Premium Trial:

Request an Annual Quote

Curtis Rosebraugh, Bruce Stillman

The US Food and Drug Administration announced the appointment last week of Curtis Rosebraugh as the new director of the Office of Drug Evaluation II. Prior to joining FDA in 2000 as a medical officer in the Division of Pulmonary and Allergy Drugs Products, Rosebraugh was an assistant professor of internal medicine at the University of Kansas-Wichita and later an assistant professor of internal medicine and internal medicine clerkship director at the University of Texas Medical Branch-Galveston. From 2003 to 2005, he served as the deputy director of the Office of Nonprescription Products and was acting director of the Division of Nonprescription Clinical Evaluation in the same office. In 2005, Rosebraugh became deputy director of the Office of Drug Evaluation II and became acting director of the office in September 2007.

Cold Spring Harbor Laboratory President Bruce Stillman has been elected to the American Academy of Arts and Sciences. Stillman has been director of the CSHL Cancer Center since 1994 and he has been president since 2003.

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.